As NLRC5 could regulate the expression of MHC genes, and its expression correlated with cytotoxicity and infiltrating level of CD8+ T cells in melanoma, we therefore asked whether high NLRC5 expression is associated with good prognosis in patients receiving immunotherapy. This evidence concerns the gene NLRC5 and melanoma.